Board of Directors
Dr John Chen CEO
Dr John Chen has various leadership and research capacities within the trading, finance and mining industries in in the last 30 years. He has a history of strong industrial, commercial experience in both China and Australia with respect to imports, retail, international finance, capital raising, mining exploration and consulting. John will bring in his scientific background, wholesale, retail and finance knowledge which will be integral and essential to HealthRegen’s commercialisation strategies.
Professor Fang-Xu Jiang Founder and Executive Director
Professor Fang-Xu Jiang is a medically-trained, world recognized stem cell biologist with extensive experience, expertise and skills in translational diabetes medicine in both Australia and China. He held various leadership roles during his academic career. He was an Associate Professor at the University of Western Australia and the founding head of, the Islet Cell Development Program in the Harry Perkins Institute of Medical Research. He is Adjunct Associate Professor of the University of Western Australia and guest/visiting/honorary Professor of four prestigious Chinese universities.
Board of Scientific Advisory
Professor Wei Wang Chair
Professor Wei Wang is Pro-Vice-Chancellor (China) of Edith Cowan University (ECU), and a member of the expert panel advising the WHO on ‘Grand Challenges in Genomics for Public Health in Developing Countries’. He is also a steering committee member of the OECD initiative on Public Health Genomics. In 2017 Professor Wang was elected as a Fellow of the Royal Society of Medicine of United Kingdom. He has published over 200 scientific papers in prestigious journals including Science, Nature Genetics and The Lancet.
Member
Professor Fang-Xu Jiang is a medically-trained, world recognized stem cell biologist with extensive experience, expertise and skills in translational diabetes medicine in both Australia and China. He held various leadership roles during his academic career. He was an Associate Professor at the University of Western Australia and the founding head of, the Islet Cell Development Program in the Harry Perkins Institute of Medical Research. He is Adjunct Associate Professor of the University of Western Australia and guest/visiting/honorary Professor of four prestigious Chinese universities.
Board of Clinical Advisory
Professor Wei Wang Member
Professor Wei Wang, Chief Physician, Professor, Head of Endocrinology Department, Xiang`an Hospital of Xiamen University, Mentors for Master and Postdoctoral Research students. Research Interests: Protective mechanism of islet beta cell function, Metabolic spectrum characteristics of diabetes mellitus and Mechanism of chronic wound and diabetic foot. Expertise: Endocrine Diseases, Diabetes, Hyperthyroidism, Diabetic foot.
